Early referral for esophageal pH monitoring is more cost-effective than prolonged empiric trials of proton-pump inhibitors for suspected gastroesophageal reflux disease.

MLA

Kleiman, David A., et al. “Early Referral for Esophageal PH Monitoring Is More Cost-Effective than Prolonged Empiric Trials of Proton-Pump Inhibitors for Suspected Gastroesophageal Reflux Disease.” Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract, vol. 18, no. 1, Jan. 2014, pp. 26–33. EBSCOhost, https://doi.org/10.1007/s11605-013-2327-x.

APA

Kleiman, D. A., Beninato, T., Bosworth, B. P., Brunaud, L., Ciecierega, T., Crawford, C. V., Jr, Turner, B. G., Fahey, T. J., 3rd, & Zarnegar, R. (2014). Early referral for esophageal pH monitoring is more cost-effective than prolonged empiric trials of proton-pump inhibitors for suspected gastroesophageal reflux disease. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract, 18(1), 26–33. https://doi.org/10.1007/s11605-013-2327-x

Chicago

Kleiman, David A, Toni Beninato, Brian P Bosworth, Laurent Brunaud, Thomas Ciecierega, Carl V Crawford Jr, Brian G Turner, Thomas J Fahey 3rd, and Rasa Zarnegar. 2014. “Early Referral for Esophageal PH Monitoring Is More Cost-Effective than Prolonged Empiric Trials of Proton-Pump Inhibitors for Suspected Gastroesophageal Reflux Disease.” Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract 18 (1): 26–33. doi:10.1007/s11605-013-2327-x.